These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 18951668

  • 1. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 2. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C, Zirlik K, Heining-Mikesch K, Ihorst G, Dierbach H, Waller CF, Veelken H.
    Cancer Res; 2006 Apr 15; 66(8):4496-502. PubMed ID: 16618777
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 4. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun 15; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 5. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 15; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun 15; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 7. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
    Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW.
    Clin Cancer Res; 2004 Dec 15; 10(24):8309-17. PubMed ID: 15623607
    [Abstract] [Full Text] [Related]

  • 8. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M.
    Expert Rev Vaccines; 2004 Apr 15; 3(2):163-70. PubMed ID: 15056042
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q.
    Expert Rev Vaccines; 2003 Jun 15; 2(3):391-8. PubMed ID: 12903804
    [Abstract] [Full Text] [Related]

  • 10. Idiotype vaccine strategies for treatment of follicular lymphoma.
    Mahaseth H, Brody JD, Sinha R, Shenoy PJ, Flowers CR.
    Future Oncol; 2011 Jan 15; 7(1):111-22. PubMed ID: 21174542
    [Abstract] [Full Text] [Related]

  • 11. [Past, present and future of anti-idiotype vaccination].
    Rodríguez Calvillo M, Inogés S, López Díaz de Cerio A, Zabalegui N, Panizo C, Hernández M, Pérez Calvo J, Prósper F, Melero I, Sánchez-Ibarrola A, Rocha E, Bendandi M.
    Rev Med Univ Navarra; 2004 Jan 15; 48(3):14-23. PubMed ID: 15622921
    [Abstract] [Full Text] [Related]

  • 12. Role of anti-idiotype vaccines in the modern treatment of human follicular lymphoma.
    Bendandi M.
    Expert Rev Anticancer Ther; 2001 Jun 15; 1(1):65-72. PubMed ID: 12113135
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody].
    Kon S.
    Gan To Kagaku Ryoho; 1988 May 15; 15(5):1685-92. PubMed ID: 3259417
    [Abstract] [Full Text] [Related]

  • 14. Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.
    Bertinetti C, Simon F, Zirlik K, Heining-Mikesch K, Pfeifer D, Osterroth F, Rosenthal FM, Veelken H.
    Eur J Haematol; 2006 Nov 15; 77(5):395-402. PubMed ID: 16879605
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, Punt CJ.
    Crit Rev Oncol Hematol; 2008 May 15; 66(2):118-34. PubMed ID: 18262431
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
    Timmerman JM.
    Adv Pharmacol; 2004 May 15; 51():271-93. PubMed ID: 15464914
    [No Abstract] [Full Text] [Related]

  • 17. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S, Nilsson B, Mellstedt H.
    Expert Rev Vaccines; 2005 Jun 15; 4(3):329-50. PubMed ID: 16026248
    [Abstract] [Full Text] [Related]

  • 18. Anti-idiotypic Immunotherapy in follicular lymphoma patients: results of a long follow-up study.
    Yáñez R, Barrios Y, Ruiz E, Cabrera R, Díaz-Espada F.
    J Immunother; 2008 Apr 15; 31(3):310-2. PubMed ID: 18317357
    [Abstract] [Full Text] [Related]

  • 19. Idiotype vaccines for lymphoma therapy.
    Inogés S, de Cerio AL, Villanueva H, Soria E, Pastor F, Bendandi M.
    Expert Rev Vaccines; 2011 Jun 15; 10(6):801-9. PubMed ID: 21692701
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic vaccine for lymphoma.
    Lee ST, Neelapu SS, Kwak LW.
    Yonsei Med J; 2007 Feb 28; 48(1):1-10. PubMed ID: 17326239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.